Teva better suited than most for China market, says CEO
China's crying need for generics plays to the Israeli company's strength, argues Jeremy Levin.
Teva Pharmaceutical Industries has yet to make any serious inroads into China, but its chief executive says the Israeli company is better suited than its rival drugmakers to serve the world's fastest growing health care market.
register with haaretz
Like us on Facebook and get articles directly in your news feed